Laboratoires Euromedis specializes in the design, manufacturing and distribution of medical equipment intended primarily for hospitals, clinics, retirement homes, physicians, pharmacies, and individuals. The products include gloves (No. 1 in France in disposable medical gloves), surgical items (sensors, pockets, scalpels, etc.), hygiene and protection equipment (white-coats, masks, shoes, etc.), parenteral approaches (needles, syringes, transfusion equipment, etc.), diagnostic products, etc.

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Market Cap	14.85M 17.17M 13.87M 12.72M 23.92M 1.63B 24.3M 163M 63.85M 819M 64.46M 63.05M 2.71B	P/E 2024	-2.05x	P/E 2025	-84.9x
Enterprise Value	4.28M 4.95M 4M 3.67M 6.9M 471M 7.01M 46.92M 18.42M 236M 18.59M 18.19M 781M	EV / Sales 2024	0.57x	EV / Sales 2025	0.01x
Free-Float	34.87%	Yield 2024 *	-	Yield 2025	-

30/04	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01/11/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2025	CI
05/05/25	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25/10/24	Laboratoires Euromedis Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2024	CI
01/11/23	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2023	CI
28/04/23	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2022	CI
01/10/22	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2022	CI
30/04/22	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2021	CI
01/10/21	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2021	CI
08/07/21	Euromedis Groupe : Malaysia rubber glove body pleads for go-ahead to restart factories	RE
27/04/21	Global markets live: Philips, Crédit Suisse, Nestlé...
24/04/21	Euromedis Groupe Reports Earnings Results for the Full Year Ended December 31, 2020	CI
24/09/20	Euromedis Groupe Reports Earnings Results for the Half Year Ended June 30, 2020	CI

01/11/25	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER SEMESTRIEL 2025	PU
01/11/25	Laboratoires Euromedis : Euromedis - Communiqué semestriel 2025	PU
11/12/24	LABORATOIRES EUROMEDIS : Ajustement du contrat de liquidité	PU
27/04/24	Laboratoires Euromedis : Euromedis - Communiqué résultat 2023	PU
30/09/22	EUROMEDIS : Rapport Financier semestriel 2022	PU

19/06	Agenda des dividendes et des AG de la semaine : session dividendes pour la galaxie Bolloré
06/05	LABORATOIRES EUROMEDIS : RAPPORT FINANCIER ANNUEL 2025
06/05	LABORATOIRES EUROMEDIS : Fin du contrat de liquidité
25/04	Laboratoires Euromedis : Communiqué résultat 2025
25/04	Laboratoires Euromedis : Résultats 2025 (7. Laboratoires Euromedis Communiqu e de presse r sultat 2025 v23.04.26)

Director	Title	Age	Since
Mathieu Roturier CHM	Chairman	49	26/11/2019
Francky Défossé BRD	Director/Board Member	39	-
Joseph Asselin BRD	Director/Board Member	52	08/03/2017

EUROMEDIS Stock Swiss Exchange

Stocks

OXEUMD

FR0000075343

Medical Equipment, Supplies & Distribution

Valuation: EUROMEDIS

Latest news : EUROMEDIS

Press Releases: EUROMEDIS

News in other languages: EUROMEDIS

Managers and Directors: EUROMEDIS

Other Medical Equipment, Supplies & Distribution

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
EUROMEDIS	-.--%	-.--%	-	-	17.17M
ABBOTT LABORATORIES	-0.14%	+2.00%	-19.71%	+2.11%	187B
MEDTRONIC PLC	+1.44%	+2.07%	-6.16%	+5.98%	112B
CENCORA, INC.	-1.40%	+2.93%	+12.39%	+72.88%	61.15B
HOYA CORPORATION	+0.65%	+3.91%	+32.37%	+55.21%	54.39B
BECTON, DICKINSON AND COMPANY	-0.12%	+6.79%	-8.60%	-37.08%	48.17B
DEXCOM, INC.	+2.08%	+1.56%	+7.47%	-23.09%	31.98B
MEDLINE INC.	+2.09%	-10.31%	-	-	30.91B
WEST PHARMACEUTICAL SERVICES, INC.	+1.57%	+3.85%	+46.93%	-11.45%	24.92B
STERIS PLC	+2.45%	+3.97%	-2.22%	+5.43%	23.15B
Average	+0.86%	+1.45%	+7.81%	+8.75%	63.64B
Weighted average by Cap.	+0.53%	+2.02%	-1.67%	+10.77%

	2024	2025
Net sales	36.41M 42.09M 34M 31.19M 58.67M 4.01B 59.6M 399M 157M 2.01B 158M 155M 6.64B	41.06M 47.47M 38.35M 35.18M 66.16M 4.52B 67.21M 450M 177M 2.26B 178M 174M 7.49B
Net income	-6.11M -7.06M -5.7M -5.23M -9.84M -672M -10M -66.92M -26.27M -337M -26.52M -25.94M -1.11B	-132K -152K -123K -113K -212K -14.5M -216K -1.44M -567K -7.27M -572K -560K -24.02M
Net Debt	8.04M 9.29M 7.51M 6.88M 12.95M 884M 13.16M 88.06M 34.56M 443M 34.89M 34.13M 1.47B	-10.57M -12.21M -9.87M -9.05M -17.02M -1.16B -17.29M -116M -45.43M -583M -45.87M -44.86M -1.93B